Literature DB >> 31707833

Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.

Renato D Lopes1, Sergio Leonardi2, Daniel M Wojdyla1, Amit N Vora3, Laine Thomas1, Robert F Storey4, Dragos Vinereanu5, Christopher B Granger1, Shaun G Goodman6,7, Ronald Aronson8, Stephan Windecker9, Holger Thiele10, Marco Valgimigli9, Roxana Mehran11, John H Alexander1.   

Abstract

Entities:  

Keywords:  anticoagulants; atrial fibrillation; coronary artery disease; percutaneous coronary intervention; stents; thrombosis

Year:  2019        PMID： 31707833     DOI： 10.1161/CIRCULATIONAHA.119.044584

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!

Authors:  Andreas Goette
Journal:  Ann Transl Med       Date:  2019-12

Review 2.  The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Authors:  Jeffrey Triska; Faris Haddadin; Luai Madanat; Ahmad Jabri; Marilyne Daher; Yochai Birnbaum; Hani Jneid
Journal:  Cardiovasc Drugs Ther       Date:  2022-07-13       Impact factor: 3.947

3.  Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention.

Authors:  Sung Soo Kim; Hyun Kuk Kim
Journal:  Korean Circ J       Date:  2021-03-05       Impact factor: 3.243

4.  Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal.

Authors:  Mattia Galli; Felicita Andreotti; Domenico D'Amario; Rocco Vergallo; Rocco A Montone; Giampaolo Niccoli; Filippo Crea
Journal:  Int J Cardiol Heart Vasc       Date:  2020-05-14

5.  Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis.

Authors:  Andreas Goette; Lars Eckardt; Marco Valgimigli; Thorsten Lewalter; Petra Laeis; Paul-Egbert Reimitz; Rüdiger Smolnik; Wolfgang Zierhut; Jan G Tijssen; Pascal Vranckx
Journal:  Clin Res Cardiol       Date:  2020-10-24       Impact factor: 5.460

Review 6.  Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.

Authors:  Andreas Schäfer; Ulrike Flierl; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

7.  Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help.

Authors:  Giuseppe Gargiulo; Andreas Goette; Pascal Vranckx; Marco Valgimigli
Journal:  Eur Heart J       Date:  2020-05-01       Impact factor: 29.983

8.  Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.

Authors:  Ceren Eyileten; Marek Postula; Daniel Jakubik; Aurel Toma; Dagmara Mirowska-Guzel; Giuseppe Patti; Giulia Renda; Jolanta M Siller-Matula
Journal:  J Clin Med       Date:  2020-04-14       Impact factor: 4.241

9.  Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

Authors:  Ziad Hijazi; Jonas Oldgren; Johan Lindbäck; John H Alexander; Marco Alings; Raffaele De Caterina; John W Eikelboom; Michael D Ezekowitz; Claes Held; Kurt Huber; Elaine M Hylek; Christopher B Granger; Renato D Lopes; Dragos Vinereanu; Agneta Siegbahn; Lars Wallentin
Journal:  JAMA Netw Open       Date:  2020-09-01

10.  Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.

Authors:  Pascal Vranckx; Marco Valgimigli; Lars Eckardt; Thorsten Lewalter; Ramunas Unikas; Francisco Marin; François Schiele; Petra Laeis; Paul-Egbert Reimitz; Rüdiger Smolnik; Wolfgang Zierhut; Jan Tijssen; Andreas Goette
Journal:  Eur Heart J       Date:  2020-12-14       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.